Figure 4
Figure 4. SAA activates distinct mitogenic pathways in Treg. (A left) Real-time quantitation of ERK1/2 and AKT phosphorylation (pERK1/2 and pAKT) by phospho flow cytometry. Teff (top) or Treg (bottom) were labeled with CFSE. Data were collected at different time points (days 1, 4, and 7) during suppression assays with SJIA plasma (n = 6), HC plasma (n = 6) or complete media (FBS, n = 4). (Right) Representative FACS plots of pERK1/2 and pAKT in Treg and Teff in suppression assays. (B left) Expression of SOCS3 in Treg and Teff (n = 7). (Right) Representative FACS plots of expression of SOCS3 in Treg and Teff.

SAA activates distinct mitogenic pathways in Treg. (A left) Real-time quantitation of ERK1/2 and AKT phosphorylation (pERK1/2 and pAKT) by phospho flow cytometry. Teff (top) or Treg (bottom) were labeled with CFSE. Data were collected at different time points (days 1, 4, and 7) during suppression assays with SJIA plasma (n = 6), HC plasma (n = 6) or complete media (FBS, n = 4). (Right) Representative FACS plots of pERK1/2 and pAKT in Treg and Teff in suppression assays. (B left) Expression of SOCS3 in Treg and Teff (n = 7). (Right) Representative FACS plots of expression of SOCS3 in Treg and Teff.

Close Modal

or Create an Account

Close Modal
Close Modal